Latest Information Update: 30 Jan 2007
At a glance
- Originator Pfizer
- Mechanism of Action Cyclic GMP phosphodiesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 06 Nov 1998 No-Development-Reported for Erectile dysfunction in USA (Unknown route)
- 04 Sep 1996 Investigation in Erectile dysfunction in USA (Unknown route)